Skip to search formSkip to main contentSkip to account menu

IMAB362

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
16 Background: Physiologically, the tight junction protein CLDN18.2 is present only in the gastric mucosa. Upon malignant… 
Review
2019
Review
2019
BackgroundIn recent years, a better understanding of tumor biology and molecular features of gastric cancer has been reached. It… 
2018
2018
ABSTRACT In healthy tissue, the tight junction protein Claudin 18.2 (CLDN18.2) is present only in the gastric mucosa. Upon… 
Highly Cited
2016
Highly Cited
2016
LBA4001Background: Claudin18.2 (CLDN18.2) is a tight junction protein expressed by several cancers including gastric and GEJ… 
Review
2016
Review
2016
  • K. ShitaraA. Ohtsu
  • The Journal of the National Comprehensive Cancer…
  • 2016
  • Corpus ID: 21625705
In recent years, various new agents have been investigated for the treatment of advanced gastric cancer (AGC). The anti-HER2… 
2015
2015
e15079 Background: IMAB362 is the first-in-class monoclonal antibody against the tight junction molecule claudin 18.2 (CLDN18.2… 
Highly Cited
2014
Highly Cited
2014
The majority of pancreatic neoplasms are characterized by a generally lethal progress within a short period of time after primary… 
2014
2014
ABSTRACT Aim: IMAB362 is a monoclonal antibody specifically targeting claudin 18 isoform 2 (CLDN18.2), which is expressed on… 
2013
2013
4080 Background: IMAB362 is a monoclonal antibody targeting isoform 2 of the tight junction component claudin 18 (CLDN18.2), a…